AtaiBeckley Inc (ATAI) – aksjekurser og nyheter

Symboler Symboler	Pris	Endring	Endring (%)	Trend	Forrige pris ved stengetid	Åpne	Høy	Lav	Volum	Markedsverdi
SIXB Materials SIXB Materials	SIXB +1,93%	1 096,94	+20,81	+1,93%	—	1 076,13	1 079,89	1 100,77	1 079,89	—	—
SIXC Communications SIXC Communications	SIXC −0,63%	602,92	−3,82	−0,63%	—	606,74	606,74	607,90	602,03	—	—
SIXE Energy SIXE Energy	SIXE +0,35%	1 253,18	+4,36	+0,35%	—	1 248,82	1 246,37	1 255,87	1 239,08	—	—
SIXI Industrials SIXI Industrials	SIXI +0,83%	1 738,74	+14,38	+0,83%	—	1 724,36	1 733,02	1 745,75	1 727,76	—	—
SIXM Financials SIXM Financials	SIXM −0,09%	635,02	−0,57	−0,09%	—	635,59	635,08	637,89	633,31	—	—
SIXR Staples SIXR Staples	SIXR +0,62%	848,41	+5,26	+0,62%	—	843,15	842,50	849,10	840,85	—	—
SIXRE Real estate SIXRE Real estate	SIXRE +0,18%	216,69	+0,40	+0,18%	—	216,29	216,29	216,91	215,24	—	—
SIXT Technology SIXT Technology	SIXT +2,36%	3 340,56	+77,15	+2,36%	—	3 263,41	3 296,25	3 342,97	3 295,42	—	—
SIXU Utilities SIXU Utilities	SIXU +0,71%	945,91	+6,67	+0,71%	—	939,24	941,57	948,11	939,87	—	—
SIXV Health care SIXV Health care	SIXV +0,34%	1 467,59	+5,03	+0,34%	—	1 462,56	1 465,03	1 471,26	1 459,66	—	—
SIXY Discretionary SIXY Discretionary	SIXY +0,64%	2 395,68	+15,28	+0,64%	—	2 380,40	2 394,92	2 412,13	2 386,94	—	—

ATAI:NASDAQ

AtaiBeckley Inc

3,97 USD

−5,58%

(−0,23) 1 D

5. mai, 14:19:35 GMT-4 · USD

Alle symboler

1 D

5 D

1 M

6 M

I år

1 Å

5 Å

MAKS

	Symbol	Pris	Endring	Endring (%)

Genererer viktig statistikk for ATAI …

Åpne

4,20 USD

Høy

4,23 USD

Lav

3,95 USD

Markedsverdi

1,45 mrd.

Snittvolum

6,23 mill.

Volum

2,35 mill.

52 u høy

6,72 USD

52 u lav

1,29 USD

EPS

−2,91 USD

Beta

1,59

Utestående aksjer

366,92 mill.

Antall ansatte

Relaterte aksjer

Definium Therapeutics Inc

Soleno Therapeutics Inc

52,92 USD

+0,03%

Nyhetssaker

Fra kilder på nettet

Newser

for 2 uker siden

AtaiBeckley (ATAI) Stock: Technical Risk Signals (Leaps) 2026-04-20 - Risk Management

Newser

for 3 uker siden

Is AtaiBeckley (ATAI) Stock Showing Strength | Price at $3.67, Down 0.95% - Gamma Alerts

Profil

atai Life Sciences is a pharmaceutical company that is developing psychedelics, other hallucinogens, entactogens, and related drugs for treatment of psychiatric conditions. It was founded in 2018 and is headquartered in Berlin, Germany. The company's pharmaceutical candidates include dimethyltryptamine, -midomafetamine, and ibogaine, as well as EGX-121, 5-MeO-DMT, psilocin, inidascamine, deuterated mitragynine, EGX-A, EGX-B, deuterated etifoxine, and arketamine. In June 2021, atai became a public company when it completed an initial public offering by listing its shares on the NASDAQ stock exchange. In January 2023, atai Life Science's leading drug candidate at the time, arketamine, failed to meet its primary endpoint in a clinical trial. Following that, the company laid off 30% of its staff. Peter Thiel is a major investor in the company. atai Life Sciences has a 22.4% stake in Compass Pathways. Wikipedia

Om AtaiBeckley Inc

Administrerende direktørFlorian Brand

Ansatte99

Grunnlagt2018

Hovedkontor-

Sektor-

Nettstedataibeckley.com

Alle verdier i USD	mars 2025	juni 2025	sep. 2025	des. 2025
Inntekt	1,56 mill.	719,00k	749,00k	1,07 mill.
Varekostnad	10,84 mill.	10,51 mill.	14,68 mill.	10,91 mill.
Direkte driftskostnader	10,84 mill.	10,51 mill.	14,68 mill.	10,91 mill.
Utgifter til forskning og utvikling	-	582,00k	-	4,00 mill.
Totale kostnader til forskning og utvikling	-	-	-	-
Salgskostnader, generelle kostnader og administrative kostnader	9,99 mill.	14,90 mill.	14,50 mill.	24,40 mill.
Driftskostnader	9,99 mill.	15,48 mill.	14,50 mill.	28,41 mill.
Totale driftskostnader	20,82 mill.	25,99 mill.	29,18 mill.	39,32 mill.
Driftsinntekter	−19,27 mill.	−25,27 mill.	−28,44 mill.	−38,25 mill.
Andre ikke-operasjonelle inntekter	−13,01 mill.	−6,33 mill.	−51,25 mill.	13,99 mill.
EBT inkludert uvanlige elementer	−26,34 mill.	−27,68 mill.	−61,00 mill.	−544,84 mill.
EBT uten uvanlige elementer	−32,54 mill.	−30,16 mill.	−79,20 mill.	−23,71 mill.
Kostnad for inntektsskatt	128,00k	65,00k	102,00k	3,00k
Faktisk avgiftssats	−0,49 %	−0,23 %	−0,17 %	-
Andre driftskostnader	-	-	-	-
Nettoinntekt	−26,43 mill.	−27,73 mill.	−61,07 mill.	−544,81 mill.
Netto fortjenestemargin	−1 699,74 %	−3 856,61 %	−8 154,07 %	−51 108,16 %
Resultat per aksje	−0,15	−0,14	−0,28	−1,73
Rente- og investeringsinntekter	186,00k	248,00k	504,00k	542,00k
Rentekostnader	−900,00k	−264,00k	-	-
Netto rentekostnader	−714,00k	−16,00k	504,00k	542,00k
Avskrivnings- og amortiseringskostnader	-	-	-	-
EBITDA	−19,05 mill.	−25,05 mill.	−28,20 mill.	−37,91 mill.
Gevinst eller tap ved salg av eiendeler	-	-	-	692,00k

AI-innhold kan inneholde feil. Finn ut mer

HjelpSend tilbakemeldingPersonvern Vilkår Ansvarsfraskrivelse

Finance

Utforskning